1. Home
  2. INLX vs NSRX Comparison

INLX vs NSRX Comparison

Compare INLX & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$5.84

Market Cap

28.1M

Sector

Technology

ML Signal

N/A

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.03

Market Cap

32.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
NSRX
Founded
1996
2019
Country
United States
Israel
Employees
N/A
7
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.1M
32.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
INLX
NSRX
Price
$5.84
$3.03
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
2.3K
40.8K
Earning Date
05-14-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,336.00
N/A
Revenue This Year
$16.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.31
$1.98
52 Week High
$14.57
$9.99

Technical Indicators

Market Signals
Indicator
INLX
NSRX
Relative Strength Index (RSI) 31.21 52.71
Support Level N/A $2.04
Resistance Level $8.52 $3.58
Average True Range (ATR) 0.24 0.27
MACD -0.10 -0.01
Stochastic Oscillator 8.52 37.71

Price Performance

Historical Comparison
INLX
NSRX

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: